---
title: "CHINARES PHARMA 's DC7001A Capsules Approved by US FDA for Clinical Trials"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/301539690.md"
description: "CHINARES PHARMAannounced that its subsidiary, Shuanghe Runchuang, received US FDA approval to initiate clinical trials for DC7001A capsules. The drug is an innovative chemical agent designed to treat systemic lupus erythematosus and cutaneous lupus erythematosus. Previously, the company obtained Chinese regulatory approval for these trials in August."
datetime: "2026-10-12T04:55:10.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/301539690.md)
  - [en](https://longbridge.com/en/news/301539690.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/301539690.md)
generator: "portal-rs"
---

# CHINARES PHARMA 's DC7001A Capsules Approved by US FDA for Clinical Trials

CHINARES PHARMA (03320.HK) -0.005 (-0.114%) Short selling $1.39M; Ratio 26.358% announced that its subsidiary Shuanghe Runchuang recently received notification from the US FDA approving clinical trials for DC7001A capsules, which are intended for the treatment of systemic lupus erythematosus.

In May 2026, Shuanghe Runchuang submitted a clinical trial application for DC7001A capsules to China's National Medical Products Administration, and received the Drug Clinical Trial Approval Notice issued by the regulator in August. The drug is registered as a Category 1 innovative chemical drug and is intended for the treatment of systemic lupus erythematosus (SLE) and cutaneous lupus erythematosus (CLE). (ha/da)(HK stocks quote is delayed for at least 15 mins.Short Selling Data as at 2026-10-12 12:25.)

### Related Stocks

- [03320.HK](https://longbridge.com/en/quote/03320.HK.md)

## Related News & Research

- [China Resources Pharmaceutical Unit Secures Approval for RMB 10 Billion Corporate Bond Issuance](https://longbridge.com/en/news/305661943.md)
- [China Resources Pharmaceutical Group Subsidiary CR Pharmaceutical Commercial’s Nine-Month Net Profit Rises to RMB 1.75 Billion](https://longbridge.com/en/news/303715107.md)
- [The bank of Nvidia is getting more ‘disciplined,’ selective](https://longbridge.com/en/news/306148745.md)
- [The Tesla Cybercab Is Now Available In Dallas](https://longbridge.com/en/news/306159915.md)
- [PRESS DIGEST-New York Times business news - November 20](https://longbridge.com/en/news/306242079.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**